Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Testosterone increases hair growth and acne in transgender men.

New treatments for male hypogonadism are effective and should be personalized.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

The best treatment varies per individual, but options include minoxidil, finasteride, PRP, and LLLT.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

The best treatment varies based on individual needs and available research.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Living with lupus as both a patient and doctor improved understanding and care for others.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.